20 LATEST RESOURCES (69 INDEXED)
Real-World Analysis of Antipsychotic Drugs’ Effect on Weight Gain: An EHR Application (Meetings-Events) · January 2024
Articles
NCBI>AMIA Annual Symposium Proceedings
Therapeutic Appropriateness of Cariprazine in the Management of Schizophrenia: Experts’ Opinion Using a Delphi Approach · September 2023
Articles
NCBI>Current Neuropharmacology
Smoking Affects the Predictive Roles of Antioxidant Enzymes in the Clinical Response to Risperidone in Schizophrenia: A Large-Scale Cohort Study · August 2023
Articles
NCBI>Current Neuropharmacology
Substance Use Specificities in Women with Psychosis: A Critical Review · July 2023
Articles
NCBI>Current Neuropharmacology
Sex Differences in Serum Prolactin Levels in Children and Adolescents on Antipsychotics: A Systematic Review and Meta-Analysis · May 2023
Articles
NCBI>Current Neuropharmacology
The Impacts of Clozapine Use on the Risk and Outcomes of COVID-19 Disease in Patients with Schizophrenia · May 2023
Articles
NCBI>Archives of Neuropsychiatry
Internalized Stigma and Resistance Against Stigma as Risk Factors for Suicide in Individuals with Schizophrenia: A Cross-Sectional Study · April 2023
Articles
NCBI>Archives of Neuropsychiatry
Early Efficacy of Antipsychotic Medications at Week 2 Predicts Subsequent Responses at Week 6 in a Large-Scale Randomized Controlled Trial · February 2023
Articles
NCBI>Current Neuropharmacology
Effect of Repetitive Transcranial Magnetic Stimulation in Inducing Weight Loss in Patients with Chronic Schizophrenia: A Randomized, Double-Blind Controlled 4-Week Study · February 2023
Articles
NCBI>Current Neuropharmacology
Neuronavigated Repetitive Transcranial Stimulation Improves Neurocognitive Functioning in Veterans with Schizophrenia: A Possible Role of BDNF Polymorphism · January 2023
Articles
NCBI>Current Neuropharmacology
Effectiveness of Acupuncture-Related Therapies on Schizophrenia: A Bayesian Network Meta-Analysis · December 2022
Articles
NCBI>Journal of Traditional Chinese Medicine
The Association Between Fear of COVID-19 and Depression, Anxiety, and Psychosis among Lebanese Chronic Patients with Schizophrenia: Any Moderating Effect of Spirituality? · October 2022
Articles
NCBI>Croatian Medical Journal
Does TMS Influence Verbal Function and Treat the Language Decline in Schizophrenia? Finding Answers via Systematic Review of Current Research · September 2022
Articles
NCBI>Psychiatria Danubina
Sex-Specific Association between Antioxidant Defense System and Therapeutic Response to Risperidone in Schizophrenia: A Prospective Longitudinal Study · August 2022
Articles
NCBI>Current Neuropharmacology
Antioxidant Enzymes and Weight Gain in Drug-Naive First-Episode Schizophrenia Patients Treated with Risperidone for 12 Weeks: A Prospective Longitudinal Study · August 2022
Articles
NCBI>Current Neuropharmacology
Feasibility, Acceptability and Evaluation of Meditation to Augment Yoga Practice among Persons Diagnosed with Schizophrenia · May 2022
Articles (Manuscripts-Versions)
PubMed Central>Acta Neuropsychiatrica
Structural and Functional MRI Brain Changes in Patients with Schizophrenia Following Electroconvulsive Therapy: A Systematic Review · May 2022
Articles
NCBI>Current Neuropharmacology
Low-Dose Ziprasidone in Combination with Sertraline for First-Episode Drug-Naive Patients with Schizophrenia: A Randomized Controlled Trial · April 2022
Articles
NCBI>Neurotherapeutics
Comparison of Patients Diagnosed with First Episode Psychosis in the Psychiatry Clinic in the 1-Year Period Before and After the COVID-19 Pandemic · April 2022
Articles
NCBI>Psychiatria Danubina
Impact of Cannabis Legalization on Healthcare Utilization for Psychosis and Schizophrenia in Colorado · April 2022
Articles (Manuscripts-Versions)
PubMed Central>International Journal on Drug Policy